DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced the global launch of PrisMax 2, the latest version of the company’s ...
Baxter International Inc. BAX recently announced the global launch of the latest version of its next-generation platform, PrisMax 2. The PrisMax 2 system aims to help streamline the delivery of ...
Innovative features inspired by clinician feedback make delivering therapy simpler and more efficient Incorporates the latest technology to increase accuracy and performance in delivering therapy for ...
The PrisMax platform, which was designed based on input from more than 650 providers around the world and received FDA clearance for use in the U.S. in July, supports the treatment of AKI with ...
Baxter International Inc. BAX recently received Emergency Use Authorization (EUA) from the FDA for Regiocit, which is the only authorized citrate-based replacement solution available in the United ...
Baxter International Inc. (NYSE:BAX) recently announced that Hamilton Health Care System will now be the first health system in the United States to utilize the former’s new PrisMax system. This new ...
System further enhances user experience and helps address the evolving challenges of the intensive care unit TrueVue digital health solutions simplify connectivity with critical hospital data systems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback